These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38552922)
1. Resolving neuroinflammatory and social deficits in ASD model mice: Dexmedetomidine downregulates NF-κB/IL-6 pathway via α2AR. Liang ZK; Xiong W; Wang C; Chen L; Zou X; Mai JW; Dong B; Guo C; Xin WJ; Luo DX; Xu T; Feng X Brain Behav Immun; 2024 Jul; 119():84-95. PubMed ID: 38552922 [TBL] [Abstract][Full Text] [Related]
2. The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4 Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alasmari F; Alasmari AF; Al-Kharashi LA; Al-Qahtani QH; Attia SM Life Sci; 2019 Nov; 237():116930. PubMed ID: 31610190 [TBL] [Abstract][Full Text] [Related]
3. Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T Almutairi MM; Nadeem A; Ansari MA; Bakheet SA; Attia SM; Albekairi TH; Alhosaini K; Algahtani M; Alsaad AMS; Al-Mazroua HA; Ahmad SF Neurotoxicology; 2022 Jul; 91():340-348. PubMed ID: 35760230 [TBL] [Abstract][Full Text] [Related]
4. 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alqahtani F; Alhoshani AR; Alasmari F; Alsaleh NB; Attia SM Pharmacol Biochem Behav; 2020 Feb; 189():172859. PubMed ID: 31982447 [TBL] [Abstract][Full Text] [Related]
5. Citalopram attenuates social behavior deficits in the BTBR T Cai Y; Wang L; Nalvarte I; Xiao R; Li X; Fan X Brain Res Bull; 2019 Aug; 150():75-85. PubMed ID: 31047973 [TBL] [Abstract][Full Text] [Related]
6. Cadmium exposure exacerbates immunological abnormalities in a BTBR T Albekairi TH; Alanazi MM; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Aldossari AA; Almanaa TN; Alwetaid MY; Alqinyah M; Alnefaie HO; Ahmad SF J Neuroimmunol; 2024 Jan; 386():578253. PubMed ID: 38064869 [TBL] [Abstract][Full Text] [Related]
7. CXCR2 antagonist SB332235 mitigates deficits in social behavior and dysregulation of Th1/Th22 and T regulatory cell-related transcription factor signaling in male BTBR T Albekairi NA; Nadeem A; Ansari MA; Attia SM; Bakheet SA; Alanazi MM; Alhamed AS; Albekairi TH; Al-Mazroua HA; Ibrahim KE; Ahmad SF Pharmacol Biochem Behav; 2022 Jun; 217():173408. PubMed ID: 35644272 [TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T Ansari MA; Nadeem A; Attia SM; Bakheet SA; Raish M; Ahmad SF Cell Signal; 2017 Aug; 36():14-24. PubMed ID: 28438638 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21/IL-21R and JAK/STAT pathway in the BTBR mouse model of autism. Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alsanea S; Al-Hosaini KA; Mahmood HM; Alzahrani MZ; Attia SM Neurotoxicology; 2020 Mar; 77():1-11. PubMed ID: 31811869 [TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):184-191. PubMed ID: 28668513 [TBL] [Abstract][Full Text] [Related]
11. Fullerenols Ameliorate Social Deficiency and Rescue Cognitive Dysfunction of BTBR T Luo J; Luo Y; Zhao M; Liu Y; Liu J; Du Z; Gong H; Wang L; Zhao J; Wang X; Gu Z; Zhao W; Liu T; Fan X Int J Nanomedicine; 2024; 19():6035-6055. PubMed ID: 38911505 [TBL] [Abstract][Full Text] [Related]
13. A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism. Alomar HA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Hussein MH; Alqarni SA; Ahmad SF J Neuroimmunol; 2023 Apr; 377():578069. PubMed ID: 36931207 [TBL] [Abstract][Full Text] [Related]
14. S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Khan MR; Alsaad AMS; Attia SM Cell Signal; 2018 Dec; 52():127-136. PubMed ID: 30213685 [TBL] [Abstract][Full Text] [Related]
15. Histamine H3 receptor antagonism modulates autism-like hyperactivity but not repetitive behaviors in BTBR T+Itpr3tf/J inbred mice. Molenhuis RT; Hutten L; Kas MJH Pharmacol Biochem Behav; 2022 Jan; 212():173304. PubMed ID: 34856309 [TBL] [Abstract][Full Text] [Related]
16. Activation of adenosine A2A receptor signaling regulates the expression of cytokines associated with immunologic dysfunction in BTBR T Ansari MA; Attia SM; Nadeem A; Bakheet SA; Raish M; Khan TH; Al-Shabanah OA; Ahmad SF Mol Cell Neurosci; 2017 Jul; 82():76-87. PubMed ID: 28465254 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Kazdoba TM; Hagerman RJ; Zolkowska D; Rogawski MA; Crawley JN Psychopharmacology (Berl); 2016 Jan; 233(2):309-23. PubMed ID: 26525567 [TBL] [Abstract][Full Text] [Related]
18. Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism. Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Attia SM Brain Res Bull; 2018 Sep; 142():328-337. PubMed ID: 30172736 [TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor. Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158 [TBL] [Abstract][Full Text] [Related]
20. DAPTA, a C-C chemokine receptor 5 (CCR5) antagonist attenuates immune aberrations by downregulating Th9/Th17 immune responses in BTBR T Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alotaibi MR; Alasmari AF; Alshammari MA; Al-Mazroua HA; Attia SM Eur J Pharmacol; 2019 Mar; 846():100-108. PubMed ID: 30658114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]